T cells from baxα transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53

EMBO Journal

Volumn 15, Issue 6, 1996, Pages 1221-1230

  Brady, Hugh J M ^a   Salomons, Gajja S ^a   Bobeldijk, René C ^a   Berns, Anton J M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Apoptosis; Bax; Bcl 2; p53; Transgenic

Indexed keywords

CYTOKINE; DEXAMETHASONE; ETOPOSIDE; GENE PRODUCT; INTERLEUKIN 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; ETIOLOGY; GAMMA RADIATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; RADIATION INJURY; T LYMPHOCYTE; THYMOCYTE; TRANSCRIPTION INITIATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0029669929     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00463.x     Document Type: Article

References (48)

1. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
2. Brady, H J.M., Pennington, D.J., Miles, C.G. and Dzierzak, E.A. (1993) CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J., 12, 4923-4932
3. Chiou, S.K., Rao, L. and White, E. (1994) Bcl-2 blocks p53-dependent apoptosis. Mol Cell. Biol., 14, 2556-2563.
4. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
5. Cleary, M.L., Smith, S.D. and Sklar, J. (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47, 19-28.
6. Cohen, J.J., Duke, R.C., Fadok, V.A. and Sellins, K.S. (1992) Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol., 10, 267-293.
7. Cox, L S. and Lane, D.P. (1995) Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. BioEssays, 17, 501-508.
8. 1 checkpoint control. Cell, 82, 675-684.
9. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr, Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
10. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
11. Fisher, D.E. (1994) Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542.
12. Green, D.R. and Scott, D.W. (1994) Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol., 6, 476-487.
13. 1 cyclin-dependent kinases. Cell, 75, 805-816
14. Kolodziej, P.A. and Young, R.A. (1991) Epitope tagging and protein surveillance. Methods Enzymol., 194, 508-519.
15. Kozak, M. (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res., 15, 8125-848
16. Krammer, P.H., Behrmann, I., Daniel, P., Dhein, J. and Debatin, K.M. (1994) Regulation of apoptosis in the immune system. Curr. Opin. Immunol., 6, 279-289.
17. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V. and Kastan, M.B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA, 89, 7491-7495.
18. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
19. Lang, G., Wotton, D , Owen, M.J., Sewell, W.A , Brown, M.H., Mason, D.Y., Crumpton, M.J. and Kioussis, D. (1988) The structure of the human CD2 gene and its expression in transgenic mice. EMBO J., 7, 1675-1682.
20. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tlsty, T.D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
21. Lotem, J. and Sachs, L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
22. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
23. Maltzman, W. and Czyzyk, L. (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4, 1689-194.
24. McDonnell, T.J., Deane, N., Platt, F.M., Nunez, G., Jaeger, U., McKearn, J.P. and Korsmeyer, S.J. (1989) bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
25. McDonnell, T.J., Meyn, R.E. and Robertson, L.E. (1995) Implications of apoptotic cell death regulation in cancer therapy. Semin. Cancer Biol., 6, 53-60.
26. Michalovitz, D , Halevy, O. and Oren, M. (1990) Conditional inhibition of transformation and of cell proliferationn by a temperature-sensitive mutant of p53. Cell, 62, 671-680.
27. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
28. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffman, B. and Reed, J.C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
29. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol Methods, 139, 271-279.
30. Oltvai, Z. and Korsmeyer, S.J. (1994) Checkpoints of duelling dimers foil death wishes. Cell, 74, 609-619.
31. Oltvai, Z., Milliman, C. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619.
32. Owen, M.J., Jenkinson, E.J., Brown, M.H., Sewell, W.A , Krissansen, G.W , Crumpton, M.J. and Owen, J.J. (1988) Murine CD2 gene expression during fetal thymus ontogeny. Eur J. Immunol., 18, 187-189
33. Roy, C., Brown, D.L., Little, J.E., Valentine, B.K., Walker, P.R., Sikorska, M., Leblanc, J. and Chaly, N. (1992) The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes. Exp. Cell Res., 200, 416-424.
34. Selivanova, G. and Wiman, K.G. (1995) p53: a cell cycle regulator activated by DNA damage. Adv. Cancer Res., 66, 143-180.
35. Selvakumaran, M., Lin, H.K., Miyashita, T., Wang, H.G., Krajewski, S., Reed, J.C., Hoffman, B. and Liebermann, D. (1994) Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
36. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O. and Korsmeyer, S.J. (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888.
37. Strasser, A., Harris, A.W. and Cory, S. (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67, 889-99.
38. Strasser, A., Harris, A.W., Jacks, T. and Cory, S. (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2 Cell, 79, 329-339.
39. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T. and Van Dyke, T. (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78, 703-711.
40. Tsujimoto, Y. and Croce, C.M. (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl Acad. Sci. USA, 83, 5214-5218.
41. Umansky, S.R. (1991) Apoptotic process in the radiation-induced death of lymphocytes. In Tome, L.D. and Cope, F.O. (eds), Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 193-208.
42. van Lohuizen, M., Verbeek, S , Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T. and Berns, A. (1989) Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56, 673-682.
43. Vaux, D.L., Cory, S. and Adams, J.M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
44. Wang, Y., Szekely, L., Okan, I., Klein, G. and Wiman, K.G. (1993) Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene, 8, 3427-3431.
45. Williams, G.T. (1991) Programmed cell death: apoptosis and oncogenesis Cell, 65, 1097-1098.
46. Wyllie, A.H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
47. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. and Wahl, G.M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles Cell, 70, 937-948
48. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.